Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells
- 4 May 2011
- journal article
- Published by Springer Nature in Investigational New Drugs
- Vol. 30 (4) , 1731-1735
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Putative biological roles of hydrogen sulfide in health and disease: a breath of not so fresh air?Trends in Pharmacological Sciences, 2008
- Osteoprotegerin upregulates endothelial cell adhesion molecule response to tumor necrosis factor-α associated with induction of angiopoietin-2☆Cardiovascular Research, 2007
- Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivoBlood, 2007
- TRAIL inhibits osteoclastic differentiation by counteracting RANKL‐dependent p27Kip1 accumulation in pre‐osteoclast precursorsJournal of Cellular Physiology, 2007
- An Increased Osteoprotegerin Serum Release Characterizes the Early Onset of Diabetes Mellitus and May Contribute to Endothelial Cell DysfunctionThe American Journal of Pathology, 2006
- Osteoprotegerin (OPG)—a potential new role in the regulation of endothelialcell phenotype and tumour angiogenesis?International Journal of Cancer, 2005
- Emerging non‐apoptotic functions of tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL)/Apo2LJournal of Cellular Physiology, 2004
- Two's company, three's a crowd: can H 2 S be the third endogenous gaseous transmitter?The FASEB Journal, 2002
- Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone DensityCell, 1997
- Human immunodeficiency virus type 1 envelope glycoprotein gp120-mediated killing of human haematopoietic progenitors (CD34+ cells)Journal of General Virology, 1992